We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
cathy
spence
cathy.spence@mft.nhs.uk
John
Blaikley
john.blaikley@manchester.ac.uk
Other diseases of the respiratory system
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Background: Lung transplantation, where old lungs are exchanged for new lungs, is used to treat patients with lung damage when there is no other treatment option. Patients require close monitoring following their transplant, with hospital check-ups every 3-4 months usually lasting most of the day. Although check-ups often result in no change to patient management, they are essential as patients have better outcomes if complications are detected quickly.
Aims: We aim to explore whether remote monitoring via an app (patientMpower) ± questionnaire (specifically designed to assess post-transplant patients' health), linked to a device to measure lung function, could replace some check-ups for lung transplant patients. This would reduce the number of hospital visits for patients.
Design: We plan to randomise patients to receive either normal care or remote monitoring (i.e. their symptoms will be evaluated using home spirometry combined with a questionnaire). 100 lung transplant recipients will be enrolled with 50 patients being assigned to either group. Patients that are randomised to remote care will be evaluated by the home spirometry combined with a questionnaire at 3 months instead of there normal clinic appointment. All patients will then be seen at 6 months in clinic. We will compare health outcomes and the costs of care between the two groups.
Funder: SBRI
Place: Cardiothoracic transplant Centre at Wythenshawe Hospital.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Interventional type: Device;Management of Care;Active Monitoring;
You can take part if:
You may not be able to take part if:
1) Consent not given 2) Not able to operate the patientMpower platform
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Manchester and funded by NHS ENGLAND .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 55699
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
